We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
James
Brenton
James.Brenton@cruk.cam.ac.uk
Magdalena
Ridley
magdalenamonika.ridley@nhs.net
Bethany
Gilson
bethany.gilson1@nhs.net
Malignant neoplasms of female genital organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
To investigate the mechanisms of treatment response in ovarian cancer through the study of sequential tissue, ascitic and circulating tumour cells and the establishment of an ex-vivo model.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
Under 18 years of age
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Magdalena
Ridley
magdalenamonika.ridley@nhs.net
Bethany
Gilson
bethany.gilson1@nhs.net
Dr
James
Brenton
James.Brenton@cruk.cam.ac.uk
The study is sponsored by CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST and funded by CANCER RESEARCH UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 14679
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
